← Open Payments lookup

DALE SUMILANG: Open Payments

NPI 1154938744 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,047 in 37 payments from 10 companies in 2025. Trend: 2023 $3,673 · 2024 $3,615 · 2025 $1,047

Food & beverage: $1,047
CompanyPaymentsAmount
ABBVIE INC.9$378
Takeda Pharmaceuticals U.S.A., Inc.6$167
Janssen Biotech, Inc.8$148
Gilead Sciences, Inc.3$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Celltrion USA Inc.3$74
QOL Medical, LLC1$33
Intercept Pharmaceuticals, Inc.1$26
Lilly USA, LLC1$25
Acella Pharmaceuticals, LLC1$25

Products named: ENTYVIO, SKYRIZI, TREMFYA, CREON, RINVOQ, XIFAXAN, VEGZELMA, Sucraid.

Industry payments across RI — which companies pay providers there.